UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19

Translational psychiatry, 2022-03, Vol.12 (1), p.94-94, Article 94

2022

Volltextzugriff (PDF)

The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs

Journal of affective disorders, 2022-09, Vol.312, p.225-234

2022

Volltextzugriff (PDF)

W68. A META-ANALYSIS OF POLYGENIC RISK SCORES FOR MOOD DISORDERS, NEUROTICISM, AND SCHIZOPHRENIA IN ANTIDEPRESSANT RESPONSE

European neuropsychopharmacology, 2021-10, Vol.51, p.e180-e180

2021

Volltextzugriff (PDF)

PHARMACOGENETICS OF CYP2C19 IN RESPONSE AND SIDE EFFECTS TO MAJOR DEPRESSIVE DISORDER TREATMENT: A MACHINE LEARNING APPROACH

European neuropsychopharmacology, 2022-10, Vol.63, p.e285-e286

2022

Volltextzugriff (PDF)

W29. METABOLIZING STATUS OF CYP2C19 IN ANTIDEPRESSANT RESPONSE AND SIDE EFFECTS: RESULTS FROM A NATURALISTIC STUDY

European neuropsychopharmacology, 2021-10, Vol.51, p.e160-e161

2021

Volltextzugriff (PDF)

Differential efficacy of escitalopram and nortriptyline ondimensional measures of depression

British journal of psychiatry, 2009-03, Vol.194 (3), p.252-259

2009

Volltextzugriff (PDF)

CYP2D6 Revisited in GENDEP: Inter-Platform Concordance

Biological psychiatry (1969), 2020-05, Vol.87 (9), p.S148

2020

Volltextzugriff (PDF)

SU85 - WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

European neuropsychopharmacology, 2019, Vol.29, p.S934-S935

2019

Volltextzugriff (PDF)

WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

European neuropsychopharmacology, 2019, Vol.29, p.S934-S935

2019

Volltextzugriff (PDF)

M74 HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

European neuropsychopharmacology, 2019-10, Vol.29, p.S206-S207

2019

Volltextzugriff (PDF)

58 PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA

European neuropsychopharmacology, 2019-10, Vol.29, p.S92-S92

2019

Volltextzugriff (PDF)

F93. CYP2D6 Revisited in GENDEP, a Multicenter Clinical Trial of Nortriptyline and Escitalopram

Biological psychiatry (1969), 2019-05, Vol.85 (10), p.S248-S249

2019

Volltextzugriff (PDF)

F105AN EXOME SEQUENCING STUDY IN TREATMENT-RESISTANT DEPRESSION

European neuropsychopharmacology, 2019, Vol.29, p.S1166-S1167

2019

Volltextzugriff (PDF)

SA84 - PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

European neuropsychopharmacology, 2019, Vol.29, p.S867-S867

2019

Volltextzugriff (PDF)

PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

European neuropsychopharmacology, 2019, Vol.29, p.S867

2019

Volltextzugriff (PDF)

F128TRANSDIAGNOSTIC EFFECT ON PSYCHOPATHOLOGY BY PSYCHOSES GENES VARIANTS

European neuropsychopharmacology, 2019, Vol.29, p.S1179-S1180

2019

Volltextzugriff (PDF)

SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES

European neuropsychopharmacology, 2019, Vol.29, p.S1246-S1246

2019

Volltextzugriff (PDF)

Possible Modulatory Role of ARC Gene Variants in Mood Disorders

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2021-02, Vol.19 (1), p.46-52

2021

Volltextzugriff (PDF)

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.25-26

2016

Volltextzugriff (PDF)

PS87. An update on prediction of treatment outcome in treatment resistant depression

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.30-30

2016

Volltextzugriff (PDF)

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STARD studies: rare variant analysis and high-density imputation

The pharmacogenomics journal, 2017-11, Vol.18 (3), p.413-421

2017

Volltextzugriff (PDF)

Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278]

Progress in neuro-psychopharmacology & biological psychiatry, 2013-10, Vol.46, p.70-70

2013

Volltextzugriff (PDF)

Dimensions of Delusions in Major Depression

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2015-04, Vol.13 (1), p.48-52

2015

Volltextzugriff (PDF)

The impact of catechol- O-methyltransferase (COMT) pharmacogenetics on treatment resistance in major depressive disorder detected by capillary electrophoresis

Toxicology letters, 2008-10, Vol.180, p.S120-S121

2008

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(35)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Psychiatry
(4)
Serotonin
(4)
Antidepressants
(3)
Biological And Medical Sciences
(3)
Medical Sciences
(3)
Miscellaneous
(3)
Pharmacology. Drug Treatments
(3)
Psychology. Psychoanalysis. Psychiatry
(3)
Public Health. Hygiene
(3)
Public Health. Hygiene-Occupational Medicine
(3)
5ht2a Receptor Polymorphism
(2)
Abstracts
(2)
Citalopram
(2)
Conditional Logistic Regression
(2)
Genomes
(2)
Genomics
(2)
Human Health Sciences
(2)
Humans
(2)
Mental Depression
(2)
Neuropharmacology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19

The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs

W68. A META-ANALYSIS OF POLYGENIC RISK SCORES FOR MOOD DISORDERS, NEUROTICISM, AND SCHIZOPHRENIA IN ANTIDEPRESSANT RESPONSE

PHARMACOGENETICS OF CYP2C19 IN RESPONSE AND SIDE EFFECTS TO MAJOR DEPRESSIVE DISORDER TREATMENT: A MACHINE LEARNING APPROACH

W29. METABOLIZING STATUS OF CYP2C19 IN ANTIDEPRESSANT RESPONSE AND SIDE EFFECTS: RESULTS FROM A NATURALISTIC STUDY

Differential efficacy of escitalopram and nortriptyline ondimensional measures of depression

CYP2D6 Revisited in GENDEP: Inter-Platform Concordance

SU85 - WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

M74 HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

58 PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA

F93. CYP2D6 Revisited in GENDEP, a Multicenter Clinical Trial of Nortriptyline and Escitalopram

F105AN EXOME SEQUENCING STUDY IN TREATMENT-RESISTANT DEPRESSION

SA84 - PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

F128TRANSDIAGNOSTIC EFFECT ON PSYCHOPATHOLOGY BY PSYCHOSES GENES VARIANTS

SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES

Possible Modulatory Role of ARC Gene Variants in Mood Disorders

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers

PS87. An update on prediction of treatment outcome in treatment resistant depression

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STARD studies: rare variant analysis and high-density imputation

Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278]

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis: e1001326

Dimensions of Delusions in Major Depression

The impact of catechol- O-methyltransferase (COMT) pharmacogenetics on treatment resistance in major depressive disorder detected by capillary electrophoresis

Aktive Filter

Suchergebnisse filtern